Guillermo Velasco

25.0k total citations · 1 hit paper
108 papers, 8.0k citations indexed

About

Guillermo Velasco is a scholar working on Pharmacology, Molecular Biology and Epidemiology. According to data from OpenAlex, Guillermo Velasco has authored 108 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pharmacology, 42 papers in Molecular Biology and 30 papers in Epidemiology. Recurrent topics in Guillermo Velasco's work include Cannabis and Cannabinoid Research (45 papers), Autophagy in Disease and Therapy (29 papers) and Neuroscience and Neuropharmacology Research (22 papers). Guillermo Velasco is often cited by papers focused on Cannabis and Cannabinoid Research (45 papers), Autophagy in Disease and Therapy (29 papers) and Neuroscience and Neuropharmacology Research (22 papers). Guillermo Velasco collaborates with scholars based in Spain, United Kingdom and Netherlands. Guillermo Velasco's co-authors include Manuel Guzmán, Cristina Sánchez, Teresa Gómez del Pulgar, Mar Lorente, María Salazar‐Roa, Arkaitz Carracedo, Cristina Blázquez, Ismael Galve‐Roperh, Sonia Hernández‐Tiedra and Juan Iovanna and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Guillermo Velasco

103 papers receiving 7.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells

2009 573 citations María Salazar‐Roa, Arkaitz Carracedo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guillermo Velasco Spain	48	4.5k	2.8k	2.0k	1.4k	1.3k	108	8.0k
Cristina Blázquez Spain	30	3.1k 0.7×	1.6k 0.6×	1.5k 0.8×	917 0.6×	630 0.5×	39	5.2k
Chiara Laezza Italy	42	3.6k 0.8×	1.9k 0.7×	1.1k 0.6×	1.2k 0.8×	315 0.2×	109	6.0k
Yasuo Okamoto Japan	43	2.0k 0.5×	2.8k 1.0×	777 0.4×	982 0.7×	385 0.3×	108	5.7k
Cristina Sánchez Spain	32	3.6k 0.8×	1.2k 0.4×	1.8k 0.9×	920 0.6×	241 0.2×	73	4.8k
Kohji Itoh Japan	31	1.7k 0.4×	1.6k 0.6×	1.0k 0.5×	345 0.2×	436 0.3×	162	4.5k
Dale G. Deutsch United States	37	4.5k 1.0×	1.6k 0.6×	2.1k 1.1×	898 0.6×	118 0.1×	73	7.4k
Moisés Garcı́a-Arencibia Spain	26	1.3k 0.3×	2.4k 0.9×	986 0.5×	317 0.2×	3.4k 2.5×	36	6.4k
G. William Rebeck United States	62	926 0.2×	4.4k 1.6×	2.1k 1.1×	1.0k 0.7×	732 0.5×	138	11.2k
Thomas P. Burris United States	64	494 0.1×	6.4k 2.3×	1.3k 0.6×	1.9k 1.3×	1.1k 0.8×	190	13.4k
László Hunyady Hungary	46	938 0.2×	4.9k 1.8×	2.1k 1.0×	664 0.5×	283 0.2×	173	7.5k

Countries citing papers authored by Guillermo Velasco

Since Specialization

Citations

This map shows the geographic impact of Guillermo Velasco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillermo Velasco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillermo Velasco more than expected).

Fields of papers citing papers by Guillermo Velasco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guillermo Velasco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillermo Velasco. The network helps show where Guillermo Velasco may publish in the future.

Co-authorship network of co-authors of Guillermo Velasco

This figure shows the co-authorship network connecting the top 25 collaborators of Guillermo Velasco. A scholar is included among the top collaborators of Guillermo Velasco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guillermo Velasco. Guillermo Velasco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bell, Christopher G., Thomas D. Nightingale, Monica de Gaetano, et al.. (2025). TRIB3 Links Endoplasmic Reticulum Stress to Impaired Efferocytosis in Atherosclerosis. Circulation Research. 137(12). 1422–1442.

Grünwald, Viktor, Axel Bex, Sylvie Rottey, et al.. (2025). Current status of adjuvant immunotherapy and relapse management in renal cell carcinoma: Insights from a European delphi study. European Journal of Cancer. 225. 115569–115569. 1 indexed citations

Cordani, Marco, Raffaele Strippoli, Amir Barzegar Behrooz, et al.. (2024). Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle. Cancer Letters. 585. 216661–216661. 11 indexed citations

Cordani, Marco, Juan Aparicio-Blanco, Ana Isabel Fraguas‐Sánchez, et al.. (2024). Preparation and characterization of PBS (Polybutylene Succinate) nanoparticles containing cannabidiol (CBD) for anticancer application. Journal of Drug Delivery Science and Technology. 97. 105833–105833. 4 indexed citations

Sepúlveda-Sánchez, Juan Manuel, Maria Martinez‐García, P. Foro, et al.. (2024). 454P Tetrahydrocannabinol (THC) / cannabidiol (CBD) oral solution in combination with temozolomide (TMZ) and radiotherapy (RT) in patients with newly diagnosed glioblastoma: Phase Ib GEINO-1601 trial. Annals of Oncology. 35. S411–S411. 1 indexed citations

Salvador, Nélida, Mar Lorente, Santiago González‐Moreno, et al.. (2023). POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1. Molecular Oncology. 18(3). 620–640. 4 indexed citations

Martinez‐García, Maria, Guillermo Velasco, Estela Pineda, et al.. (2022). Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial. Cancers. 14(10). 2393–2393. 16 indexed citations

Castillo‐Lluva, Sonia, Nélida Salvador, Adrián Blanco‐Gómez, et al.. (2021). The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast Cancer. Cancers. 13(21). 5307–5307. 10 indexed citations

Sáiz-Ladera, Cristina, Claudia Fuoco, Daniela Barilá, et al.. (2020). mTOR Inhibition Leads to Src-Mediated EGFR Internalisation and Degradation in Glioma Cells. Cancers. 12(8). 2266–2266. 12 indexed citations

10.

Gomez, Ingrid, Mark P. Ariaans, Richard A. Kammerer, et al.. (2017). Angiopoietin-1 enhances neutrophil chemotaxis in vitro and migration in vivo through interaction with CD18 and release of CCL4. Scientific Reports. 7(1). 2332–2332. 10 indexed citations

11.

Pannese, Maria, et al.. (2016). The cannabinoid receptor CB₁contributes to the development of ectopic lesions in a mouse model of endometriosis. Human Reproduction. 32(1). 175–184. 15 indexed citations

12.

Velasco, Guillermo, Cristina Sánchez, & Manuel Guzmán. (2016). Anticancer Mechanisms of Cannabinoids. Current Oncology. 23(11). 23–32. 197 indexed citations

13.

Erazo, Tatiana, Mar Lorente, Patricia Fernández‐Nogueira, et al.. (2015). The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase. Clinical Cancer Research. 22(10). 2508–2519. 59 indexed citations

14.

Hamidi, Tewfik, Carla E. Cano, Daniel Grasso, et al.. (2012). NUPR1 works against the metabolic stress-induced autophagy-associated cell death in pancreatic cancer cells. Autophagy. 9(1). 95–97. 24 indexed citations

15.

Torres, Sofía, Mar Lorente, Fátima Rodríguez-Fornés, et al.. (2011). A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma. Molecular Cancer Therapeutics. 10(1). 90–103. 234 indexed citations

16.

Walter, Dagmar, Marco Wachtel, María Salazar‐Roa, et al.. (2009). Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma. Molecular Cancer Therapeutics. 8(7). 1838–1845. 42 indexed citations

17.

Blázquez, Cristina, María Salazar‐Roa, Arkaitz Carracedo, et al.. (2008). Cannabinoids Inhibit Glioma Cell Invasion by Down-regulating Matrix Metalloproteinase-2 Expression. Cancer Research. 68(6). 1945–1952. 151 indexed citations

18.

Lefkove, Benjamin, Lan Bo Chen, Baskaran Govindarajan, et al.. (2008). The antidepressant sertraline downregulates Akt and has activity against melanoma cells. Pigment Cell & Melanoma Research. 21(4). 451–456. 54 indexed citations

19.

Carracedo, Arkaitz, Mar Lorente, Ainara Egia, et al.. (2006). The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells. Cancer Cell. 9(4). 301–312. 292 indexed citations

20.

Carracedo, Arkaitz, Meritxell Gironella, Mar Lorente, et al.. (2006). Cannabinoids Induce Apoptosis of Pancreatic Tumor Cells via Endoplasmic Reticulum Stress–Related Genes. Cancer Research. 66(13). 6748–6755. 293 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact